Concepedia

Jennifer L. Shoemaker

JL

4

Publications

438

Citations

4

H-Index

2005

Active since

Affiliations

University of Arkansas for Medical Sciences(Current)

Jennifer L. Shoemaker is an author at University of Arkansas for Medical Sciences specializing in redox biology, atherosclerosis, and oxidative stress.

Top concepts

Publications per year

2005–2007

4

Publications

4

The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset

Jennifer L. Shoemaker, Kathryn A. Seely, Ronald L. Reed et al. · Journal of Neurochemistry · 2007 · 207 citations · Full text

Agonist-Directed Trafficking of Response by Endocannabinoids Acting at CB2 Receptors

Jennifer L. Shoemaker, Michael B. Ruckle, Philip R. Mayeux et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 130 citations

The Endocannabinoid Noladin Ether Acts as a Full Agonist at Human CB2 Cannabinoid Receptors

Jennifer L. Shoemaker, Biny K. Joseph, Michael B. Ruckle et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 78 citations

NAD(P)H oxidase contributes to the progression of remote hepatic parenchymal injury and endothelial dysfunction, but not microvascular perfusion deficits

Robert B. Dorman, Christian Wunder, Hamida Saba et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2005 · 23 citations

, , +19

Rows per page

1–4 of 4